Rolf van Hulten

769 total citations
27 papers, 588 citations indexed

About

Rolf van Hulten is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Experimental and Cognitive Psychology. According to data from OpenAlex, Rolf van Hulten has authored 27 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Geriatrics and Gerontology and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in Rolf van Hulten's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Schizophrenia research and treatment (9 papers) and Sleep and related disorders (7 papers). Rolf van Hulten is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Schizophrenia research and treatment (9 papers) and Sleep and related disorders (7 papers). Rolf van Hulten collaborates with scholars based in Netherlands, New Zealand and Norway. Rolf van Hulten's co-authors include Eibert R. Heerdink, Toine C. G. Egberts, Hubert G. M. Leufkens, Albert Bakker, Erica C.G. van Geffen, Marcel L. Bouvy, Liset van Dijk, Helga Gardarsdóttir, Lyda Blom and Dag Isacson and has published in prestigious journals such as Social Science & Medicine, Patient Education and Counseling and BMJ Open.

In The Last Decade

Rolf van Hulten

26 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf van Hulten Netherlands 15 201 191 147 115 113 27 588
Stephan Mühlig Germany 15 153 0.8× 114 0.6× 86 0.6× 117 1.0× 58 0.5× 68 896
Martin Frisher United Kingdom 14 178 0.9× 130 0.7× 117 0.8× 72 0.6× 27 0.2× 48 756
Caterina Vicens Spain 14 163 0.8× 152 0.8× 210 1.4× 106 0.9× 31 0.3× 37 685
Leena Saastamoinen Finland 16 247 1.2× 240 1.3× 180 1.2× 41 0.4× 112 1.0× 56 803
Monica Zolezzi Qatar 15 146 0.7× 169 0.9× 71 0.5× 196 1.7× 33 0.3× 69 782
Lauren B. Gerlach United States 16 283 1.4× 177 0.9× 93 0.6× 39 0.3× 24 0.2× 51 668
Maria Teresa Peñarrubia‐María Spain 17 381 1.9× 111 0.6× 55 0.4× 98 0.9× 140 1.2× 45 736
Ilse R. Wiechers United States 14 151 0.8× 150 0.8× 84 0.6× 77 0.7× 13 0.1× 39 651
Julia Kirkham Canada 12 239 1.2× 160 0.8× 32 0.2× 41 0.4× 37 0.3× 32 591
Jean Grenier Canada 13 87 0.4× 125 0.7× 145 1.0× 84 0.7× 21 0.2× 33 534

Countries citing papers authored by Rolf van Hulten

Since Specialization
Citations

This map shows the geographic impact of Rolf van Hulten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf van Hulten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf van Hulten more than expected).

Fields of papers citing papers by Rolf van Hulten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf van Hulten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf van Hulten. The network helps show where Rolf van Hulten may publish in the future.

Co-authorship network of co-authors of Rolf van Hulten

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf van Hulten. A scholar is included among the top collaborators of Rolf van Hulten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf van Hulten. Rolf van Hulten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hulten, Rolf van, et al.. (2017). Exploring the concept of patient centred communication for the pharmacy practice. International Journal of Clinical Pharmacy. 39(6). 1145–1156. 35 indexed citations
2.
Smet, Peter A. G. M. De, Rolf van Hulten, Rob Horne, et al.. (2016). Beliefs about inhaled corticosteroids: Comparison of community pharmacists, pharmacy technicians and patients with asthma. Journal of Asthma. 53(10). 1051–1058. 9 indexed citations
3.
Smet, Peter A. G. M. De, et al.. (2016). Communication during counseling sessions about inhaled corticosteroids at the community pharmacy. Patient Preference and Adherence. Volume 10. 2239–2254. 17 indexed citations
4.
Meer, Helene G. van der, Hans Wouters, Rolf van Hulten, Niesko Pras, & Katja Taxis. (2015). Decreasing the load? Is a Multidisciplinary Multistep Medication Review in older people an effective intervention to reduce a patient's Drug Burden Index? Protocol of a randomised controlled trial. BMJ Open. 5(12). e009213–e009213. 15 indexed citations
5.
Hulten, Rolf van, et al.. (2011). Communication with patients who are dispensed a first prescription of chronic medication in the community pharmacy. Patient Education and Counseling. 83(3). 417–422. 33 indexed citations
6.
Geffen, Erica C.G. van, et al.. (2010). The decision to continue or discontinue treatment: Experiences and beliefs of users of selective serotonin-reuptake inhibitors in the initial months—A qualitative study. Research in Social and Administrative Pharmacy. 7(2). 134–150. 48 indexed citations
7.
Geffen, Erica C.G. van, Eibert R. Heerdink, Jacqueline G. Hugtenburg, et al.. (2010). Patients' perceptions and illness severity at start of antidepressant treatment in general practice. International Journal of Pharmacy Practice. 18(4). 217–225. 15 indexed citations
8.
Dijk, Liset van, et al.. (2009). Afschaffing vergoeding heeft beperkt effect: Slechts 1 op 10 stopt nabenzomaatregel. Data Archiving and Networked Services (DANS). 144(49). 28–31. 1 indexed citations
9.
Geffen, Erica C.G. van, Helga Gardarsdóttir, Rolf van Hulten, et al.. (2009). Initiation of antidepressant therapy: do patients follow the GP's prescription?. British Journal of General Practice. 59(559). 81–87. 86 indexed citations
10.
Geffen, Erica C.G. van, et al.. (2007). Patients' concerns about and problems experienced with discontinuation of antidepressants. International Journal of Pharmacy Practice. 15(4). 291–293. 7 indexed citations
11.
Geffen, Erica C.G. van, et al.. (2007). Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system. European Journal of Clinical Pharmacology. 63(12). 1193–1199. 44 indexed citations
12.
Hulten, Rolf van, et al.. (2007). Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor Treatment. Annals of Pharmacotherapy. 42(2). 218–225. 39 indexed citations
13.
Hulten, Rolf van, et al.. (2005). Initial benzodiazepine use and improved health-related quality of life. Pharmacy World & Science. 27(1). 41–46. 4 indexed citations
14.
Hulten, Rolf van, et al.. (2003). The impact of attitudes and beliefs on length of benzodiazepine use: a study among inexperienced and experienced benzodiazepine users. Social Science & Medicine. 56(6). 1345–1354. 24 indexed citations
15.
Hulten, Rolf van, et al.. (2003). Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. European Journal of Clinical Pharmacology. 58(10). 689–694. 25 indexed citations
16.
Hulten, Rolf van, Dag Isacson, Albert Bakker, & Hubert G. M. Leufkens. (2002). Comparing patterns of long‐term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiology and Drug Safety. 12(1). 49–53. 40 indexed citations
17.
Hulten, Rolf van, et al.. (2001). Determinants of change in the intention to use benzodiazepines.. Pharmacy World & Science. 23(2). 70–75. 5 indexed citations
18.
Hulten, Rolf van, et al.. (2000). Characteristics of current benzodiazepine users as indicators of differences in physical and mental health.. Pharmacy World & Science. 22(3). 96–101. 14 indexed citations
19.
Hulten, Rolf van, Eibert R. Heerdink, Albert Bakker, & Hubert G. M. Leufkens. (1999). Benzodiazepine pathways in the chronically ill. Pharmacoepidemiology and Drug Safety. 8(5). 325–330. 8 indexed citations
20.
Hulten, Rolf van, Hubert G. M. Leufkens, & Albert Bakker. (1998). Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.. Pharmacy World & Science. 20(2). 78–82. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Mühlig Breakdown of academic impact, for papers by Martin Frisher Breakdown of academic impact, for papers by Caterina Vicens Breakdown of academic impact, for papers by Leena Saastamoinen Breakdown of academic impact, for papers by Monica Zolezzi Breakdown of academic impact, for papers by Lauren B. Gerlach Breakdown of academic impact, for papers by Maria Teresa Peñarrubia‐María Breakdown of academic impact, for papers by Ilse R. Wiechers Breakdown of academic impact, for papers by Julia Kirkham Breakdown of academic impact, for papers by Jean Grenier
Rankless by CCL
2026